Broadway Wealth Solutions’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$382K Sell
2,081
-746
-26% -$126K 0.17% 51
2026
Q2
$352K Buy
2,827
+363
+15% +$63K 0.16% 54
2026
Q1
$489K Buy
2,464
+1,222
+98% +$285K 0.25% 35
2025
Q4
$333K Buy
1,242
+79
+7% +$20.1K 0.18% 58
2025
Q3
$287K Buy
1,163
+177
+18% +$46.2K 0.16% 75
2025
Q2
$295K Buy
986
+116
+13% +$35.3K 0.18% 62
2025
Q1
$272K Sell
870
-25
-3% -$8.83K 0.2% 64
2024
Q4
$315K Buy
+895
New +$322K 0.24% 50

Other funds holding ACN

Broadway Wealth Solutions's ACN Position: Q3 2026 in Review

Broadway Wealth Solutions reduced its Accenture (ACN) stake by 26% in Q3 2026, selling an estimated $126K and leaving 2,081 shares worth $382K. The position accounts for 0.17% of the portfolio, ranked #51.

Broadway Wealth Solutions first reported a position in ACN in Q4 2024 and has held it in 8 quarters since. The position peaked at $489K in Q1 2026. 1,357 funds tracked by Wall St. Rank hold ACN as of Q3 2026.

  • Broadway Wealth Solutions held 2,081 shares of Accenture worth $382K as of Q3 2026.
  • Broadway Wealth Solutions sold 746 Accenture shares in Q3 2026, an estimated $126K.
  • Accenture made up 0.17% of Broadway Wealth Solutions's portfolio in Q3 2026, its #51 holding.
  • Broadway Wealth Solutions first reported a position in Accenture in Q4 2024 and has held it in 8 quarters since.
  • Broadway Wealth Solutions's Accenture position peaked at $489K in Q1 2026.
  • 1,357 funds tracked by Wall St. Rank held Accenture as of Q3 2026.

Based on Broadway Wealth Solutions's 13F filing for Q3 2026, filed 21 Oct 2026.